PT - JOURNAL ARTICLE AU - Agbata, B. C. AU - Emmanuel, Ogala AU - Bashir, Tenuche AU - William, Obeng-Denteh TI - Mathematical Analysis of COVID-19 Transmission Dynamics with a Case Study of Nigeria and its Computer Simulation AID - 10.1101/2020.10.20.20216473 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.20.20216473 4099 - http://medrxiv.org/content/early/2020/10/23/2020.10.20.20216473.short 4100 - http://medrxiv.org/content/early/2020/10/23/2020.10.20.20216473.full AB - In this article, we formulated a mathematical model for the spread of the COVID-19 disease and we introduced quarantined and isolated compartments. The next generation matrix method was adopted to compute the basic reproduction number (R0) in order to assess the transmission dynamics of the COVID-19 deadly disease. Stability analysis of the disease free equilibrium is investigated based on the basic reproduction number and the result shows that it is locally and asymptotically stable for R0 less than 1. Numerical calculation of the basic reproduction number revealed that R0 < 1 which means that the disease can be eradicated from Nigeria. The study shows that isolation, quarantine and other government policies like social distancing and lockdown are the best approaches to control the pernicious nature of COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Clinical Trial6633482Funding StatementWe didn't get funding from any sourceAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The article was submitted to Haudawi journal of MathematicsAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used are gotten from some publications and some realistically estimated